Lakefront Biotherapeutics | GLPG - Fremdkapital





Fremdkapital Veränderung Datum
argenx SE USD 36M 432K 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Biogen USD 6.29B 1.7M 2026-03
Genmab DKK 5.14B 5.01B 2025-12
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
GRIFOLS EUR 9.08B 612M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Incyte USD 28.42M 994K 2026-06
Merck EUR 10.8B 72M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.49B 42M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 13.84B 1.88B 2026-03
UCB EUR 2.18B 634M 2025-12
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12